Update shared on04 Aug 2025
Fair value Increased 19%The modest increases in both net profit margin and future P/E suggest improved profitability and sustained growth expectations for HealthCare Global Enterprises, supporting the upward revision of the consensus analyst price target from ₹567.29 to ₹603.88.
What's in the News
- KKR Asian Fund IV SCSp, managed by KKR & Co. Inc., and KIA EBT II Scheme 1 completed the acquisition of a 50.4% stake in HealthCare Global Enterprises Limited from Aceso Company Pte Ltd for INR 34.28 billion, with regulatory approvals secured.
- Mr. Meghraj Arvindrao Gore resigned as CEO, and Dr. Manish Mattoo, an experienced healthcare executive formerly with Apollo Hospitals, was appointed as the new CEO effective June 30, 2025.
- Board meetings were scheduled to consider and approve both audited and unaudited financial results for the quarters and year ended March 31, 2025, and June 30, 2025.
Valuation Changes
Summary of Valuation Changes for HealthCare Global Enterprises
- The Consensus Analyst Price Target has risen from ₹567.29 to ₹603.88.
- The Net Profit Margin for HealthCare Global Enterprises has risen slightly from 7.90% to 8.11%.
- The Future P/E for HealthCare Global Enterprises has risen slightly from 43.90x to 44.78x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.